B87.81 Genitourinary myiasis

Name of the Condition

• Genitourinary myiasis

Summary

Genitourinary myiasis is a parasitic infestation involving live fly larvae (maggots) in the genitourinary tract. The condition occurs when flies deposit eggs or larvae in genitourinary sites, which then hatch and feed on the host's tissue. It may affect structures such as the urethra, bladder, or reproductive organs, with severity varying by fly species and host factors.

Causes

Genitourinary myiasis is caused by the larvae of certain fly species, which deposit eggs or larvae in genitourinary sites. The larvae hatch and feed on the host's tissue, leading to infestation. Transmission typically occurs through contact with contaminated environments, animals, or flies, with larvae targeting mucous membranes or internal cavities of the genitourinary system.

Risk Factors

• Poor hygiene or inadequate sanitation.
• Living in or traveling to regions with high fly populations.
• Underlying anatomical or physiological conditions that expose genitourinary sites.
• Prolonged exposure to environments with decaying organic matter.
• Immunocompromised states or pre-existing tissue abnormalities.

Symptoms

• Crawling or moving sensations in the genitourinary area.
• Visible larvae or maggots in genitourinary orifices or cavities.
• Localized pain, irritation, or discomfort.
• Dysuria, frequency, or urgency.
• Discharge or bleeding from the affected site.
• Systemic symptoms (e.g., fever) in severe or invasive cases.

Diagnosis

Diagnosis is primarily clinical, based on the presence of larvae in genitourinary sites. Healthcare providers may examine the affected area, review patient history (e.g., exposure to flies or contaminated environments), and use imaging or endoscopic procedures to confirm infestation. Laboratory tests may rule out other conditions, but larval identification is key.

Treatment Options

Treatment involves mechanical removal of larvae, often via irrigation or extraction. Topical or systemic antiparasitic agents may be used to eliminate remaining larvae. Antibiotics are prescribed if secondary bacterial infection is present. Pain management and wound care address associated symptoms. Follow-up ensures complete resolution and prevents recurrence.

Prognosis and Follow-Up

Prognosis is generally good with prompt treatment, though severe infestations may lead to complications. Follow-up appointments monitor for recurrence, assess healing, and address any residual symptoms. Immunocompromised patients or those with underlying conditions may require extended care.

Complications

• Secondary bacterial infections.
• Tissue damage or scarring.
• Urinary obstruction or dysfunction.
• Systemic spread in severe cases.
• Psychological distress from infestation.

Lifestyle & Prevention

• Maintain good personal hygiene, especially in genitourinary areas.
• Avoid contact with flies or contaminated environments.
• Use protective clothing in high-risk regions.
• Seek prompt care for genitourinary injuries or infections.
• Practice safe sanitation to reduce fly breeding sites.

When to Seek Professional Help

Seek medical attention if you experience genitourinary symptoms (e.g., pain, discharge, or visible larvae) or suspect exposure to flies. Immediate care is needed for severe pain, fever, or signs of systemic infection.

Tips for Medical Coders

Code B87.81 is specific to genitourinary myiasis. Document the anatomical site (e.g., urethra, bladder) and confirm larval presence. Include details on exposure history, diagnostic methods, and treatment to support coding accuracy. Ensure documentation aligns with clinical findings for proper code assignment.